Browsing Category
Corona Virus
Covaxin trial to begin in Bengaluru hospital on Wed
The Phase-III clinical trial of Covid-19 vaccine (Covaxin) being developed by Bharat Biotech would begin at the privately-run Vydehi multi-specialty hospital here from Wednesday, an official said on Tuesday."The ICMR (Indian Council of…
Phase 2 and 3 clinical trials for Sputnik vaccine commence
Dr. Reddys Laboratories Ltd. and Russian Direct Investment Fund (RDIF) announced on Tuesday that they have commenced adaptive Phase 2 and 3 clinical trials for Sputnik V vaccine in India for Covid-19 after receiving the necessary clearance…
Most lungs recover well in 3 months after Covid: Study
Researchers have revealed that lung tissue of patients who suffered severely from Covid-19 shows good recovery in three months in most cases.The study from Radboud University in the Netherlands, published in the journal Clinical Infectious…
India inches closer to 93L Covid cases
With 44,489 new cases of Covid infections, India's total cases reached 92,66,705 on Thursday. It is the 19th straight day when India reported less than 50,000 cases in a day.The last time daily new cases crossed the 50,000-threshold was on…
Covaxin Phase-3 trials begin in AIIMS
The Phase-III human trials of indigenous Covid-19 vaccine Covaxin began at All India Institute of Medical Science (AIIMS) in New Delhi on Thursday.M V Padma Srivastava, the chief of Neurosciences Centre and three other volunteers received…
Global availability of Covid vaccine for public only by mid-2021: Moody’s
While recent news about the high effectiveness of two coronavirus vaccines is a promising sign in the effort to combat the pandemic, a vaccine for Covid-19 will not be widely distributed before mid-2021, Moodys Investors Service said on…
Russia’s Sputnik V Covid-19 vaccine claimed to be 95% effective
Russia's Sputnik V vaccine has been found to be more than 95 per cent effective against Covid-19 in the second interim analysis of Phase 3 clinical trial data, its developers said on Tuesday.The analysis was based on data from volunteers…
Markets zoom on hopes of Covid vaccine in India; banking stocks rise
Optimism over the introduction of an Civod-19 vaccine in India along with continued foreign fund inflows boosted the Indian stock markets on Tuesday.In terms of global cues, positive development over US President-elect Joe Biden's team…
Thailand extends Covid-19 emergency rule until mid-Jan
Thailand on Monday announced the extension of the emergency rule imposed against the Covid-19 pandemic from December until mid-January 2021 aimed at the curbing the further spread of the virus.The Cabinet of Ministers earlier on Monday…
Moderna Covid-19 vaccine to cost govts $25-$37 per dose: CEO
Governments seeking to purchase Moderna's potential Covid-19 vaccine may have to shell out $25 and $37 per dose, depending on the size of the order, the company's CEO Stephane Bancel told German weekly 'Welt am Sonntag' (WamS).Bancel said…